ArticleScience translational medicine2020

Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Elinor Willis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.